Tony Avril

4.6k total citations · 1 hit paper
48 papers, 2.8k citations indexed

About

Tony Avril is a scholar working on Immunology, Cell Biology and Molecular Biology. According to data from OpenAlex, Tony Avril has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 19 papers in Cell Biology and 16 papers in Molecular Biology. Recurrent topics in Tony Avril's work include Endoplasmic Reticulum Stress and Disease (18 papers), Immune Cell Function and Interaction (13 papers) and Glioma Diagnosis and Treatment (12 papers). Tony Avril is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (18 papers), Immune Cell Function and Interaction (13 papers) and Glioma Diagnosis and Treatment (12 papers). Tony Avril collaborates with scholars based in France, United Kingdom and United States. Tony Avril's co-authors include Éric Chevet, Paul R. Crocker, Élodie Vauléon, Hery Urra, Claudio Hetz, Véronique Quillien, Estefanie Dufey, Jean Mosser, Abderrahmane Hamlat and Hugh J. Willison and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Brain Research.

In The Last Decade

Tony Avril

47 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endoplasmic Reticulum Stress and the Hallmarks of Cancer

2016 424 citations Hery Urra, Estefanie Dufey et al. Trends in cancer profile →

Peers

Countries citing papers authored by Tony Avril

Since Specialization

Citations

This map shows the geographic impact of Tony Avril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Avril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Avril more than expected).

Fields of papers citing papers by Tony Avril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Avril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Avril. The network helps show where Tony Avril may publish in the future.

Co-authorship network of co-authors of Tony Avril

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Avril. A scholar is included among the top collaborators of Tony Avril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Avril. Tony Avril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protocol to generate two distinct standard-of-care murine glioblastoma models for evaluating novel combination therapies 2024 ·STAR Protocols ·Raphaël Pineau, Pierre‐Jean Le Reste, Tony Avril, Ulrich Jarry, Éric Chevet, (unknown)	0
2	IRE1 RNase controls CD95-mediated cell death 2024 ·EMBO Reports ·(unknown), (unknown), (unknown), Raphaël Pineau, Alexandra Papaioannou, Xingchen Zhou, (unknown), (unknown), Matthieu Le Gallo, Tony Avril, Éric Chevet, Élodie Lafont	6
3	Death sentence: The tale of a fallen endoplasmic reticulum 2021 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), Éric Chevet, Tony Avril, Élodie Lafont	32
4	SARS-CoV-2 integral membrane proteins shape the serological responses of patients with COVID-19 2021 ·iScience ·(unknown), (unknown), Gwénaële Jégou, Leif A. Eriksson, Matthieu Le Gallo, Vincent Thibault, Éric Chevet, Florence Godey, Tony Avril	9
5	Emerging Roles of the Endoplasmic Reticulum Associated Unfolded Protein Response in Cancer Cell Migration and Invasion 2019 ·Cancers ·(unknown), Chloé Sauzay, Hery Urra, Claudio Hetz, Éric Chevet, Tony Avril	72
6	CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule 2019 ·Frontiers in Cell and Developmental Biology ·Chloé Sauzay, Konstantinos Voutetakis, Aristotelis Chatziioannou, Éric Chevet, Tony Avril	72
7	Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1 2018 ·The FASEB Journal ·Akram Obiedat, Einat Seidel, (unknown), (unknown), Pinchas Tsukerman, Konstantinos Voutetakis, Aristotelis Chatziioannou, (unknown), Tony Avril, Éric Chevet, Ofer Mandelboim, Boaz Tirosh	30
8	The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line 2018 ·BMC Cancer ·Annabelle Monnier, (unknown), Régis Bouvet, Amandine Etcheverry, Marc Aubry, Tony Avril, Véronique Quillien, Éric Chevet, Jean Mosser	10
9	CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma 2017 ·Clinical Cancer Research ·Tony Avril, Amandine Etcheverry, Raphaël Pineau, Joanna Obacz, Gwénaële Jégou, Florence Jouan, Pierre‐Jean Le Reste, Masumeh Hatami, Rivka R. Colen, Brett L. Carlson, Paul A. Decker, Jann N. Sarkaria, Élodie Vauléon, (unknown), Anne Clavreul, Jean Mosser, Éric Chevet, Véronique Quillien	34
10	Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives 2017 ·Science Signaling ·Joanna Obacz, Tony Avril, Pierre‐Jean Le Reste, Hery Urra, Véronique Quillien, Claudio Hetz, Éric Chevet	102
11	Endoplasmic Reticulum Stress and the Hallmarks of Cancer breakdown → 2016 ·Trends in cancer ·Hery Urra, Estefanie Dufey, Tony Avril, Éric Chevet, Claudio Hetz	424
12	Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins 2014 ·Journal of Neuro-Oncology ·Anne Clavreul, Amandine Etcheverry, (unknown), Audrey Rousseau, Tony Avril, Cécile Henry, Jean Mosser, Philippe Meneï	22
13	Proteomic analysis of glioblastomas: What is the best brain control sample? 2013 ·Journal of Proteomics ·Jean‐Michel Lemée, Emmanuelle Com, Anne Clavreul, Tony Avril, Véronique Quillien, Marie de Tayrac, Charles Pineau, Philippe Meneï	25
14	Immune genes are associated with human glioblastoma pathology and patient survival 2012 ·BMC Medical Genomics ·Élodie Vauléon, Tony Avril, Abderrahmane Hamlat, Amandine Etcheverry, (unknown), Philippe Meneï, Jean Mosser, Véronique Quillien, Marc Aubry	42
15	Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach 2011 ·Proteome Science ·Brigitte Collet, Nathalie Guitton, Stéphan Saïkali, Tony Avril, Charles Pineau, Abderrahmane Hamlat, Jean Mosser, Véronique Quillien	38
16	Human Glioblastoma Stem‐Like Cells are More Sensitive to Allogeneic NK and T Cell‐Mediated Killing Compared with Serum‐Cultured Glioblastoma Cells 2011 ·Brain Pathology ·Tony Avril, Élodie Vauléon, Abderrahmane Hamlat, Stéphan Saïkali, Amandine Etcheverry, Caroline Delmas, Sylma Diabira, Jean Mosser, Véronique Quillien	84
17	Not All Polyriboinosinic-polyribocytidylic Acids (Poly I:C) are Equivalent for Inducing Maturation of Dendritic Cells 2009 ·Journal of Immunotherapy ·Tony Avril, Marie de Tayrac, Claudine Leberre, Véronique Quillien	19
18	Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy 2006 ·Journal of Neuro-Oncology ·Stéphan Saïkali, Tony Avril, Brigitte Collet, Abderrahmane Hamlat, Jean‐Yves Bansard, Bernard Drénou, Y Guégan, Véronique Quillien	111
19	Human Choriocarcinoma Cell Resistance to Natural Killer Lysis Due to Defective Triggering of Natural Killer Cells1 2003 ·Biology of Reproduction ·Tony Avril, Sophie Iochmann, Denys Brand, P. Bardos, (unknown), Gilles Thibault	14
20	Trophoblast Cell Line Resistance to NK Lysis Mainly Involves an HLA Class I-Independent Mechanism 1999 ·The Journal of Immunology ·Tony Avril, (unknown), (unknown), José Boucraut, Philippe Le Bouteiller, P. Bardos, Gilles Thibault	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact